Role of SLC25A39 in IFNγ-induced MHC-I Expression in a Pancreatic Cancer Cell Model
Immunotherapy has revolutionized cancer treatment. One of the key mediators of tumor-immune interactions is the major histocompatibility complex (MHC) class I (MHC-I), a protein expressed on the surface of cancer cells to present tumor-derived antigens to CD8+ T cells, and loss or downregulation of MHC-I contributes to...